205 related articles for article (PubMed ID: 19216563)
41. Synthesis and Preliminary Evaluation of Phenyl 4-123I-Iodophenylcarbamate for Visualization of Cholinesterases Associated with Alzheimer Disease Pathology.
Macdonald IR; Reid GA; Pottie IR; Martin E; Darvesh S
J Nucl Med; 2016 Feb; 57(2):297-302. PubMed ID: 26541777
[TBL] [Abstract][Full Text] [Related]
42.
Li Z; Zhang X; Zhang X; Cui M; Lu J; Pan X; Zhang X
J Med Chem; 2016 Dec; 59(23):10577-10585. PubMed ID: 27933958
[TBL] [Abstract][Full Text] [Related]
43. Design, synthesis, and fluorescence lifetime study of benzothiazole derivatives for imaging of amyloids.
Kumar N; Tiwari AK; Kakkar D; Saini N; Chand M; Mishra AK
Cancer Biother Radiopharm; 2010 Oct; 25(5):571-5. PubMed ID: 20874487
[TBL] [Abstract][Full Text] [Related]
44. Radiosynthesis and in vivo evaluation of a ¹⁸F-labelled styryl-benzoxazole derivative for β-amyloid targeting.
Ribeiro Morais G; Gano L; Kniess T; Bergmann R; Abrunhosa A; Santos I; Paulo A
Appl Radiat Isot; 2013 Dec; 82():100-4. PubMed ID: 23974304
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and biological evaluation of 99mTc, Re-monoamine-monoamide conjugated to 2-(4-aminophenyl)benzothiazole as potential probes for beta-amyloid plaques in the brain.
Chen X; Yu P; Zhang L; Liu B
Bioorg Med Chem Lett; 2008 Feb; 18(4):1442-5. PubMed ID: 18191400
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and evaluation of benzothiophene derivatives as ligands for imaging beta-amyloid plaques in Alzheimer's disease.
Chang YS; Jeong JM; Lee YS; Kim HW; Ganesha RB; Kim YJ; Lee DS; Chung JK; Lee MC
Nucl Med Biol; 2006 Aug; 33(6):811-20. PubMed ID: 16934700
[TBL] [Abstract][Full Text] [Related]
47. Biphenyls labeled with technetium 99m for imaging beta-amyloid plaques in the brain.
Zhuang ZP; Kung MP; Hou C; Ploessl K; Kung HF
Nucl Med Biol; 2005 Feb; 32(2):171-84. PubMed ID: 15721763
[TBL] [Abstract][Full Text] [Related]
48. Radioiodinated flavones for in vivo imaging of beta-amyloid plaques in the brain.
Ono M; Yoshida N; Ishibashi K; Haratake M; Arano Y; Mori H; Nakayama M
J Med Chem; 2005 Nov; 48(23):7253-60. PubMed ID: 16279784
[TBL] [Abstract][Full Text] [Related]
49. Novel quinoxaline derivatives for in vivo imaging of β-amyloid plaques in the brain.
Cui M; Ono M; Kimura H; Liu B; Saji H
Bioorg Med Chem Lett; 2011 Jul; 21(14):4193-6. PubMed ID: 21684159
[TBL] [Abstract][Full Text] [Related]
50. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
51. Fluoro-pegylated chalcones as positron emission tomography probes for in vivo imaging of beta-amyloid plaques in Alzheimer's disease.
Ono M; Watanabe R; Kawashima H; Cheng Y; Kimura H; Watanabe H; Haratake M; Saji H; Nakayama M
J Med Chem; 2009 Oct; 52(20):6394-401. PubMed ID: 19757822
[TBL] [Abstract][Full Text] [Related]
52. Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.
Okamura N; Yanai K
IDrugs; 2010 Dec; 13(12):890-9. PubMed ID: 21154149
[TBL] [Abstract][Full Text] [Related]
53. [
Rivera-Marrero S; Fernández-Maza L; León-Chaviano S; Sablón-Carrazana M; Bencomo-Martínez A; Perera-Pintado A; Prats-Capote A; Zoppolo F; Kreimerman I; Pardo T; Reyes L; Balcerzyk M; Dubed-Bandomo G; Mercerón-Martínez D; Espinosa-Rodríguez LA; Engler H; Savio E; Rodríguez-Tanty C
Curr Radiopharm; 2019; 12(1):58-71. PubMed ID: 30605068
[TBL] [Abstract][Full Text] [Related]
54. 11C-labelled PIB analogues as potential tracer agents for in vivo imaging of amyloid beta in Alzheimer's disease.
Serdons K; Verduyckt T; Vanderghinste D; Borghgraef P; Cleynhens J; Van Leuven F; Kung H; Bormans G; Verbruggen A
Eur J Med Chem; 2009 Apr; 44(4):1415-26. PubMed ID: 18992967
[TBL] [Abstract][Full Text] [Related]
55. (R)- and (S)-
Song J; Zhang X; Zhao Y; Yang H; Zhang J; Zhang X; Dai J; Cui M
Eur J Med Chem; 2017 Jul; 134():271-280. PubMed ID: 28419929
[TBL] [Abstract][Full Text] [Related]
56. Structure-Activity Relationship of 2-Arylquinolines as PET Imaging Tracers for Tau Pathology in Alzheimer Disease.
Tago T; Furumoto S; Okamura N; Harada R; Adachi H; Ishikawa Y; Yanai K; Iwata R; Kudo Y
J Nucl Med; 2016 Apr; 57(4):608-14. PubMed ID: 26697966
[TBL] [Abstract][Full Text] [Related]
57. Synthesis and In Vitro and In Vivo Evaluation of
Zheng W; Huang Y; Chen H; Jiang Z; Yu Z; Yang T; Zhang L; Cheng X; Liu Y; Liu Q; Ji X; Wu Z
ACS Chem Neurosci; 2023 Mar; 14(5):988-1003. PubMed ID: 36795539
[TBL] [Abstract][Full Text] [Related]
58. Development of amyloid imaging PET probes for an early diagnosis of Alzheimer's disease.
Kudo Y
Minim Invasive Ther Allied Technol; 2006; 15(4):209-13. PubMed ID: 16966133
[TBL] [Abstract][Full Text] [Related]
59. ¹⁸F-labeled 2-phenylquinoxaline derivatives as potential positron emission tomography probes for in vivo imaging of β-amyloid plaques.
Yu P; Cui M; Wang X; Zhang X; Li Z; Yang Y; Jia J; Zhang J; Ono M; Saji H; Jia H; Liu B
Eur J Med Chem; 2012 Nov; 57():51-8. PubMed ID: 23047223
[TBL] [Abstract][Full Text] [Related]
60. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
Xia CF; Arteaga J; Chen G; Gangadharmath U; Gomez LF; Kasi D; Lam C; Liang Q; Liu C; Mocharla VP; Mu F; Sinha A; Su H; Szardenings AK; Walsh JC; Wang E; Yu C; Zhang W; Zhao T; Kolb HC
Alzheimers Dement; 2013 Nov; 9(6):666-76. PubMed ID: 23411393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
